Notch Activation Is Dispensable for D, L-Sulforaphane-Mediated Inhibition of Human Prostate Cancer Cell Migration by Hahm, ER et al.
Notch Activation Is Dispensable for D, L-Sulforaphane-
Mediated Inhibition of Human Prostate Cancer Cell
Migration
Eun-Ryeong Hahm1, Kumar Chandra-Kuntal1, Dhimant Desai2, Shantu Amin2, Shivendra V. Singh1*
1Department of Pharmacology and Chemical Biology, and University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania,
United States of America, 2Department of Pharmacology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States of America
Abstract
D, L-Sulforaphane (SFN), a synthetic racemic analog of broccoli constituent L-sulforaphane, is a highly promising cancer
chemopreventive agent with in vivo efficacy against chemically-induced as well as oncogene-driven cancer in preclinical
rodent models. Cancer chemopreventive effect of SFN is characterized by G2/M phase cell cycle arrest, apoptosis induction,
and inhibition of cell migration and invasion. Moreover, SFN inhibits multiple oncogenic signaling pathways often
hyperactive in human cancers, including nuclear factor-kB, Akt, signal transducer and activator of transcription 3, and
androgen receptor. The present study was designed to determine the role of Notch signaling, which is constitutively active
in many human cancers, in anticancer effects of SFN using prostate cancer cells as a model. Exposure of human prostate
cancer cells (PC-3, LNCaP, and/or LNCaP-C4-2B) to SFN as well as its naturally-occurring thio-, sulfinyl-, and sulfonyl-analogs
resulted in cleavage (activation) of Notch1, Notch2, and Notch4, which was accompanied by a decrease in levels of full-
length Notch forms especially at the 16- and 24-hour time points. The SFN-mediated cleavage of Notch isoforms was
associated with its transcriptional activation as evidenced by RBP-Jk-, HES-1A/B- and HEY-1 luciferase reporter assays.
Migration of PC-3 and LNCaP cells was decreased significantly by RNA interference of Notch1 and Notch2, but not Notch4.
Furthermore, SFN-mediated inhibition of PC-3 and LNCaP cell migration was only marginally affected by knockdown of
Notch1 and Notch2. Strikingly, SFN administration to Transgenic Adenocarcinoma of Mouse Prostate transgenic mice failed
to increase levels of cleaved Notch1, cleaved Notch2, and HES-1 proteins in vivo in prostatic intraepithelial neoplasia, well-
differentiated carcinoma or poorly-differentiated prostate cancer lesions. These results indicate that Notch activation is
largely dispensable for SFN-mediated inhibition of cell migration, which should be viewed as a therapeutic advantage as
Notch activation is frequent in human prostate cancers.
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Introduction
D, L-Sulforaphane (SFN), a synthetic racemic analog of
broccoli-derived L-isomer (L-SFN), is a highly promising cancer
chemopreventive agent with remarkable activity in preclinical
animal models [1,2]. Talalay and co-workers were the first to
observe prevention of 9,10-dimethyl-1,2-benzanthracene-induced
mammary cancer in rats by this compound [3]. Cancer
chemopreventive efficacy of SFN or L-SFN was subsequently
extended to other chemical carcinogenesis models. For example,
SFN administration was shown to suppress azoxymethane-induced
colonic aberrant crypt foci in rats [4]. Likewise, SFN treatment
resulted in prevention of benzo[a]pyrene-induced forestomach
cancer and inhibition of malignant progression of lung adenomas
induced by tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyr-
idyl)-1-butanone in mice [5,6]. More recent studies have utilized
transgenic mouse models to establish chemopreventive efficacy of
SFN against oncogene-driven cancers. For instance, dietary
administration of 300 and 600 ppm SFN for 3 weeks to
ApcMin/+ mice resulted in suppression of polyps in the small
intestine in a dose-dependent manner [7]. Previous studies from
our laboratory have shown that oral gavage of 6 mmol SFN (three
times per week) beginning at 6–7 weeks of age significantly
inhibited incidence and burden of prostatic intraepithelial neo-
plasia (PIN) and/or well-differentiated prostate cancer (WD) as
well as pulmonary metastasis multiplicity in Transgenic Adeno-
carcinoma of Mouse Prostate (TRAMP) mice without causing any
side effects [8]. Consistent with these data [8], 8-week old TRAMP
mice fed with 240 mg of broccoli sprouts/mouse/day exhibited
a significant decrease in prostate tumor growth in another study
[9]. Furthermore, growth of PC-3 human prostate cancer cells
xenografted in male athymic mice was retarded significantly by
oral treatment with SFN [10].
Because of promising results in preclinical rodent models [3–
8,10] elucidation of the mechanism underlying cancer chemopre-
ventive response to SFN has been the topic of intense research
over the past decade. Mechanisms contributing to cancer
chemoprevention by SFN include: inhibition of CYP2E1 [11],
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cell cycle arrest [12,13], apoptosis induction [12,14], suppression
of angiogenesis [15], inhibition of histone deacetylase [16], protein
binding [17], induction of phase 2 enzymes [18], epigenetic
repression of hTERT [19], and inhibition of self-renewal of breast
cancer stem cells [20]. Mechanistic studies using cultured cancer
cells have also revealed SFN-mediated suppression of various
oncogenic pathways often hyperactive in human cancers, in-
cluding nuclear factor-kB, androgen receptor, Bcl-2, Bcl-xL, and
signal transducer and activator of transcription 3 [14,21–23].
While activation of signal transducer and activator of transcription
3 confers modest protection against SFN-induced apoptosis,
mitochondria-derived reactive oxygen species (ROS) provide
initial signal for apoptosis commitment in cancer cells exposed
to this agent [14,24].
The Notch signaling has been implicated in prostate cancer
development and metastasis [25–28]. For example, a study
involving tumor samples from 154 men showed overexpression
of Jagged-1, a Notch ligand, in metastatic prostate cancer
compared with localized cancer and benign prostate disease
[26]. Likewise, Bin Hafeez et al. [27] found increased expression of
Notch1 in prostate cancers. Moreover, knockdown of Notch1
inhibited invasion of human prostate cancer cells in association
with inhibition of matrix metalloproteinase-9 (MMP-9) and
urokinase plasminogen activator [27]. Down-regulation of Notch1
and its ligand Jagged-1 has been shown to inhibit proliferation of
prostate cancer cells [28]. The present study used cultured human
prostate cancer cells (PC-3, LNCaP, and LNCaP-C4-2B), and
dorsolateral prostate tissues from control and SFN-treated
TRAMP mice [8] to determine the role of Notch1, Notch2, and
Notch4 in anticancer effects of SFN.
Results
SFN Treatment Increased Levels of Cleaved Notch1,
Cleaved Notch2, and Cleaved Notch4 in Cultured Human
Prostate Cancer Cells
Notch activation involves binding of the receptor to adjoining
ligands followed by a conformational change within the receptor
and Notch cleavage mediated by the c-secretase complex at a site
located within the Notch transmembrane domain [29]. The net
outcome of these reactions is release of the Notch intracellular
domain into the cytoplasm, which then translocates to the nucleus
to regulate target gene expression [25,29]. We used PC-3 (an
androgen-independent human prostate cancer cell line lacking
functional p53), LNCaP (an androgen-responsive human prostate
cancer cell line with wild-type p53), and LNCaP-C4-2B (an
androgen-independent variant of the LNCaP cell line) to study the
role of Notch signaling in anticancer effects of SFN. Levels of
cleaved Notch1, cleaved Notch2, and cleaved Notch4 proteins
were increased markedly upon treatment with SFN in PC-3
(Fig. 1A), LNCaP (Fig. 1B), and LNCaP-C4-2B cells (Fig. 1C),
albeit with different kinetics. For example, unlike LNCaP cells
(Fig. 1B), cleavage of the Notch1 upon treatment with SFN was
transient (increased cleavage seen only at 8 hour- time point) in
PC-3 cells (Fig. 1A). Molecular basis for cell line-specific
differences in Notch activation by SFN is not clear, but Notch
activation by SFN was accompanied by a decrease in the levels of
full-length Notch1, Notch2, and Notch4 in each cell line especially
at the 16- and 24-hour time points (Fig. 1A–C). Notably, Notch2
was generally more sensitive to cleavage by SFN compared with
Notch1 or Notch4 (Fig. 1A–C). Collectively, these results indicated
that SFN treatment resulted in cleavage of Notch1, Notch2, and
Notch4 in both androgen-independent and androgen-responsive
human prostate cancer cells.
Effects of Naturally-Occurring Analogs of SFN on Notch
Activation in PC-3 and LNCaP Cells
We used naturally-occurring thio-, sulfinyl-, and sulfonyl-
analogs of SFN with different alkyl chain length (Fig. 2A) to
determine if activation of Notch was unique to SFN. Eight-hour
exposure of PC-3 (Fig. 2B) and LNCaP cells (Fig. 2C) to thio-
(Iberverin, Erucin, and Berteroin) and sulfinyl-analogs (Iberin and
Alyssin) resulted in cleavage of Notch1 and Notch2 (Fig. 2B, C).
Furthermore, the thio- and sulfinyl-analogs were relatively more
potent in causing cleavage of Notch1 and Notch2 in comparison
with sulfonyl-analogs (Cheirolin, Erysolin, and Alyssin Sulfone) in
both PC-3 (Fig. 2B) and LNCaP cells (Fig. 2C). Surprisingly, levels
of cleaved Notch4 were decreased to varying extent upon
treatment with thio- and sulfinyl-analogs but not sulfonyl-analogs
in both cell lines. Collectively, these results indicated that the
naturally-occurring thio- and sulfinyl-analogs of SFN were
effective in causing cleavage of Notch1 and Notch2. On the other
hand, Notch4 activation seems unique to SFN.
Effect of SFN Treatment on Transcriptional Activity of
Notch
We proceeded to test whether SFN-mediated cleavage of
Notch1, Notch2, and Notch4 was accompanied by transcriptional
activation of Notch using luciferase reporter assays. The RBP-Jk
[C protein binding factor 1/Suppressor of Hairless/Lag1 (CBF1/
Su (H)/Lag 1)] is a direct downstream modulator of Notch
signaling [25,29]. Exposure of PC-3 and LNCaP cells to 20 mM
SFN for 8 and/or 24 hours resulted in a statistically significant
increase in RBP-Jk luciferase reporter activity (Fig. 3A). Consistent
with these results, the levels of nuclear HES-1, a downstream
target of Notch, were increased upon 24-hour treatment of PC-3
and LNCaP cells with SFN compared with dimethyl sulfoxide
(DMSO)-treated control cells (Fig. 3B). The luciferase activity
associated with Notch target genesHES-1A/B and HEY-1 (Fig. 3C,
D) were also increased significantly upon treatment with 20 mM
SFN in prostate cancer cells. Together, these observations
indicated that SFN treatment caused transcriptional activation of
Notch in cultured prostate cancer cells.
Effect of RNA Interference of Notch1 on SFN-Mediated
Inhibition of PC-3 and LNCaP Cell Migration
Down-regulation of Notch1 was shown to inhibit prostate
cancer cell migration and invasion [28]. We therefore designed
experiments using PC-3 and LNCaP cells to determine the
consequences of Notch1 activation on SFN-mediated inhibition of
cell migration. The PC-3 and LNCaP cells transiently transfected
with a Notch1-targeted siRNA exhibited 80% or greater decrease
in the levels of full-length Notch1 when compared with the cells
transfected with a control siRNA (Fig. 4A). RNA interference of
Notch1 alone resulted in a significant decrease in PC-3 and
LNCaP cell migration (Fig. 4B, C). However, the SFN-mediated
inhibition of PC-3 and LNCaP cell migration was only marginally
affected by knockdown of Notch1 (Fig. 4C). Based on these results,
we conclude that Notch1 activation is largely dispensable for SFN-
mediated inhibition of prostate cancer cell migration.
Effect of Notch2 Protein Knockdown on SFN-Mediated
Inhibition of PC-3 and LNCaP Cell Migration
We have shown previously that silencing of full-length Notch2
protein significantly decreases migration ability of both PC-3 and
LNCaP cells [30]. We proceeded to test whether Notch2
activation by SFN affected its ability to inhibit PC-3 and LNCaP
cell migration. Level of the full-length Notch2 protein was
Sulforaphane Activates Notch
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decreased by .90% and 60%, respectively, upon transient
transfection of PC-3 and LNCaP cells with a Notch2-targeted
siRNA when compared with the corresponding cells transfected
with the control siRNA (Fig. 5A). Consistent with our earlier
observations [30], knockdown of Notch2 protein alone reduced
PC-3 and LNCaP cell migration (Fig. 5B, C). The SFN-mediated
inhibition of PC-3 and LNCaP cell migration was modestly
augmented by RNA interference of Notch2 (Fig. 5C). For
example, PC-3 cell migration was inhibited by 43% and 18%
(equals 59% inhibition), respectively, after 24-hour treatment of
control siRNA transfected cells with 10 mM SFN and RNA
interference of Notch2 alone. Migration of PC-3 cell was inhibited
by 67% upon treatment with SFN in Notch2 silenced cells. These
results suggested that Notch2 activation by SFN imparted
marginal resistance against its inhibitory effect on cell migration.
O’Neill et al [31] have shown previously that Notch2 regulates
apoptosis at least in MDA-MB-231 human breast cancer cells.
Therefore, it was only logical to determine if Notch2 activation
Figure 1. D, L-Sulforaphane (SFN) causes cleavage of Notch1, Notch2, and Notch4 proteins in PC-3 and LNCaP cells. Immunoblotting
for cleaved and full-length Notch1, Notch2, and Notch4 using lysates from (A) PC-3, (B) LNCaP, and (C) LNCaP-C4-2B cells after 8-, 16-, or 24-hour
treatment with DMSO or SFN (10 or 20 mM). Blots were stripped and re-probed with anti-actin antibody as a loading control. Immunoblotting for
each protein was done at least twice using independently prepared lysates. Numbers above band represent changes in protein levels relative to
corresponding DMSO-treated control.
doi:10.1371/journal.pone.0044957.g001
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affected SFN-induced apoptosis. As shown in Fig. 5D, knockdown
of Notch2 protein alone did not have any meaningful impact on
histone-associated DNA fragment release into the cytosol, which is
a well-accepted method for quantitation of apoptosis. The SFN-
mediated histone-associated DNA fragment release into the
cytosol was slightly abrogated upon RNA interference of Notch2
in LNCaP cells, but this differential did not reach statistical
significance in the PC-3 cell line (Fig. 5D). Because of marginal
effects and cell line-specific differences, we conclude that Notch2
activation has minimal impact on ability of SFN to induce
apoptosis at least in prostate cancer cells.
Notch4 Activation Was Dispensable for SFN-Mediated
Inhibition of PC-3 Cell Migration
Next, we proceeded to determine the role of Notch4 activation
in SFN-mediated inhibition of cell migration using PC-3 cells.
Level of full-length Notch4 protein was decreased by 70% upon
Figure 2. Effects of analogs of D, L-sulforaphane on cleavage of Notch isoforms. (A) Chemical names, common names, and chemical
formulae of analogs used in the present study. Immunoblotting for cleaved Notch1, Notch2, and Notch4 using lysates from (B) PC-3, and (C) LNCaP
cells after 8-hour treatment with DMSO or different analogs (10 or 20 mM). Blots were stripped and re-probed with anti-actin antibody as a loading
control. Immunoblotting for each protein was done at least twice using independently prepared lysates. Numbers above band represent changes in
protein levels relative to DMSO-treated control.
doi:10.1371/journal.pone.0044957.g002
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transient transfection of PC-3 cells with a Notch4-targeted siRNA
compared with cells transfected with the control siRNA (Fig. 6A).
Unlike Notch1 (Fig. 4C) or Notch2 (Fig. 5C), RNA interference of
Notch4 alone had minimal effect on PC-3 cell migration (Fig. 6B,
C). Moreover, inhibition of PC-3 cell migration resulting from
SFN exposure was not influenced by RNA interference of Notch4
(Fig. 6C). Thus activation of Notch4 was also dispensable for SFN-
mediated inhibition of PC-3 cell migration at least in PC-3 cells.
Figure 3. D, L-Sulforaphane (SFN) increases transcriptional activity of Notch in prostate cancer cells. (A) Effect of SFN treatment on RBP-
Jk luciferase reporter activity (a measure of transcriptional activity of Notch) in PC-3 and LNCaP cells after 8- or 24-hour treatment with DMSO or
20 mM SFN. (B) Immunofluorescence microscopic images depicting nuclear levels of HES-1 protein in PC-3 and LNCaP cells after 24-hour treatment
with DMSO or 10 mM SFN (6100 objective magnification). (C) HES-1A/B luciferase reporter activity in PC-3 and LNCaP cells after 8- or 24-hour
treatment with DMSO or 20 mM SFN. (D) HEY-1 (PC-3 cells) or HES-1A/B (LNCaP-C4-2B cells) luciferase reporter activity after 8- or 24-hour treatment
with DMSO or 20 mM SFN. In panels A, C, and D, results shown are mean 6 SD (n = 6; combined data from two independent experiments each
performed in triplicate). *Significantly different (P,0.05) compared with corresponding DMSO-treated control by Student’s t-test (panels A, C, and D).
Each experiment was performed twice.
doi:10.1371/journal.pone.0044957.g003
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Similar studies using Notch4 siRNA were not performed in
LNCaP cells.
Imzmunohistochemical Analysis for Cleaved Notch1,
Cleaved Notch2, and HES-1 Proteins in Dorsolateral
Prostate Tissue Sections from Control and SFN-Treated
TRAMP Mice
We used archived paraffin-embedded prostate tissues from our
previously completed TRAMP study [8] to determine in vivo effect
of SFN administration on levels of cleaved Notch1, cleaved
Notch2, and HES-1 proteins. Representative images for cleaved
Notch1, cleaved Notch2, and HES-1 protein expression in the
PIN, WD, and poorly-differentiated prostate cancer (PD) of
control and SFN-treated TRAMP mice are shown in Fig. 7A.
Surprisingly, SFN administration failed to increase levels of these
proteins in PIN, WD, and PD. However, a modest but significant
decrease in overall level of cleaved Notch2 (combined expression
in PIN, WD, and PD) was discernible in the dorsolateral prostate
of SFN-treated TRAMP mice compared with that of control
TRAMP mice.
Discussion
Notch signaling is quite complex involving interplay between
four receptor (Notch1, Notch2, Notch3, and Notch4) and five
ligands [Jagged1, Jagged2, Delta-like and ligands (Dll1, Dll3, and
Dll4)] [25,29]. Notch signaling is implicated in cell fate de-
Figure 4. Effect of Notch1 silencing on D, L-sulforaphane (SFN)-mediated inhibition of PC-3 and LNCaP cell migration. (A)
Immunoblotting for full-length Notch1 protein using lysates from PC-3 and LNCaP cells transiently transfected with a control (nonspecific) siRNA or
a Notch1-targeted siRNA. (B) Representative images (Boyden chamber assay) depicting migration of PC-3 and LNCaP cells transfected with a control
(nonspecific) siRNA or a Notch1-targeted siRNA and treated for 24 hours with DMSO or 10 mM SFN (6100 magnification). (C) Quantitation of PC-3 and
LNCaP cell migration from data shown in panel B. Two to three fields on each filter were scored for cell migration under an inverted microscope. Data
represent percent cell migration normalized to control siRNA-transfected cells treated with DMSO (mean 6 SD, n = 6; combined data from two
independent experiments each performed in triplicate). Significantly different (P,0.05) acompared with respective DMSO-treated controls (cells
transfected with control siRNA or Notch1-targeted siRNA), and bbetween control siRNA transfected cells and Notch1-targeted siRNA transfected cells
by one-way ANOVA followed by Bonferroni’s multiple comparison test. Each experiment was performed twice.
doi:10.1371/journal.pone.0044957.g004
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Figure 5. Effect of Notch2 knockdown on cellular responses to D, L-sulforaphane (SFN). (A) Immunoblotting for full-length Notch2 protein
using lysates from PC-3 and LNCaP cells transiently transfected with a control (nonspecific) siRNA or a Notch2-targeted siRNA. (B) Representative
images (Boyden chamber assay) depicting migration of PC-3 and LNCaP cells transfected with a control (nonspecific) siRNA or a Notch2-targeted
siRNA and treated for 24 hours with DMSO or 10 mM SFN (6100 magnification). (C) Quantitation of PC-3 and LNCaP cell migration from data shown in
panel B. Two to three fields on each filter were scored for cell migration under an inverted microscope. Data represent percent cell migration
normalized to control siRNA transfected cells treated with DMSO (mean 6 SD, n = 6; combined data from two independent experiments each
performed in triplicate). (D) Analysis of histone-associated DNA fragment release into the cytosol in PC-3 and LNCaP cells transfected with a control
(nonspecific) siRNA or a Notch2-targeted siRNA and treated for 24 hours with DMSO or SFN. Data represent enrichment of histone-associated DNA
fragment release into the cytosol relative to control siRNA transfected cells treated with DMSO (mean 6 SD, n = 6; combined data from two
independent experiments each performed in triplicate). In panels C and D, significantly different (P,0.05) acompared with respective DMSO-treated
controls (cells transfected with control siRNA or Notch2-targeted siRNA), and bbetween control siRNA transfected cells and Notch2-targeted siRNA
transfected cells by one-way ANOVA followed by Bonferroni’s multiple comparison test. Each experiment was performed twice.
doi:10.1371/journal.pone.0044957.g005
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termination in embryonic and adult tissues [32,33], and normal
prostatic development as well as in pathogenesis of prostate
cancers [25]. Overexpression of Jagged-1 was shown in metastatic
prostate cancer compared with localized cancer and benign
prostate disease [26]. Moreover, Notch1 knockdown was shown to
inhibit the MMP-9 and invasion of PC-3 cells [27]. Down-
regulation of Jagged1 has been shown to inhibit proliferation of
prostate cancer cells [28]. RNA interference of Notch1 inhibits
prostate cancer cell migration and invasion [28]. The present
study shows that SFN treatment activates Notch signaling in
human prostate cancer cell lines irrespective of the androgen-
responsiveness. The SFN-mediated activation of Notch1, Notch2,
and Notch4 is characterized by their cleavage and increased
transcriptional activity. Activation of Notch1 and Notch2, but not
Notch4, is not unique to SFN as some of its naturally-occurring
analogs are effective in causing cleavage of both Notch1 and
Notch2 in PC-3 and LNCaP cells. Consistent with literature data
[28,] we also found that knockdown of Notch1 and Notch2
reduces migration of prostate cancer cells irrespective of the
androgen-responsiveness. Surprisingly, Notch activation by SFN
has minimal impact on its ability to inhibit prostate cancer cell
migration. Specifically, knockdown of Notch1, Notch2 or Notch4
has no impact at all or only marginal effect on SFN-mediated
inhibition of prostate cancer cell migration. These observations
indicate that Notch activation is dispensable for SFN-mediated
inhibition of prostate cancer cell migration.
Evidence continues to accumulate to indicate that structural
differences in naturally-occurring isothiocyanates (ITC) can pro-
foundly affect their activity. For example, autophagy induction by
SFN serves to protect against apoptosis [34]. To the contrary,
autophagy contributes to cell death induction by phenethyl
isothiocyanate (PEITC) [35], which is a naturally-occurring
constituent of watercress with structural similarity to SFN (i.e.,
presence of the ITC functional group). The present study provides
yet another example to illustrate mechanistic differences in
structurally-related ITC compounds (e.g., SFN and PEITC). We
have shown previously that, unlike SFN (present study) Notch
activation by PEITC impedes its inhibitory effect on prostate
cancer cell migration [30]. These observations underscore caution
in extrapolation of mechanistic results between structurally-
different ITC compounds.
Activation of Notch2 by overexpression of its intracellular
domain has been shown to promote apoptosis in MDA-MB-231
human breast cancer cells [31]. Because apoptosis induction is
considered an important mechanism in cancer chemoprevention
by SFN [12,14], it was of interest to determine the consequences of
Notch2 activation on proapoptotic response to SFN. Unlike
MDA-MB-231 cells, knockdown of Notch2 has no impact on
apoptosis in either PC-3 or LNCaP cells. Moreover, SFN-induced
apoptosis was minimally affected by knockdown of Notch2 in PC-
3 and LNCaP cells. Thus proapoptotic role of Notch2 may be
a phenomenon unique to the MDA-MB-231 cells.
We have shown previously that SFN administration inhibits
incidence and burden (affected area) of PIN and WD, but not PD,
as well as pulmonary metastasis multiplicity in TRAMP mice [8].
Interestingly, SFN administration is unable to increase levels of
cleaved Notch1, cleaved Notch2 or HES-1 in vivo in the
dorsolateral prostate of TRAMP mice (present study). On one
hand, these results suggest that prevention of prostate cancer by
SFN in TRAMP mice is not related to Notch signaling. At the
same time, the possibility that a more intense dosing regimen of
SFN (e.g., higher concentrations and daily administration) may be
required to elicit Notch activation in vivo can’t be discarded.
Observed discrepancy between in vitro and in vivo systems
concerning effect of SFN on notch activation may also be related
to tumor microenvironment. However, further work is needed to
explore these possibilities.
In conclusion, the results of the present not only reveal in vitro
and in vivo differences in effect of SFN on Notch activation but also
indicate that activation of Notch1, Notch2, and Notch4 is largely
dispensable for cellular responses to SFN (e.g., inhibition of cell
migration or apoptosis) at least in human prostate cancer cells.
Figure 6. Notch4 is dispensable for D, L-sulforaphane (SFN)-
mediated inhibition of PC-3 cell migration. (A) Immunoblotting
for full-length Notch4 protein using lysates from PC-3 cells transiently
transfected with a control (nonspecific) siRNA or a Notch4-targeted
siRNA. (B) Representative images (Boyden chamber assay) depicting
migration of PC-3 cells transfected with a control (nonspecific) siRNA or
a Notch4-targeted siRNA and treated for 24 hours with DMSO or 10 mM
SFN (6100 objective magnification). (C) Quantitation of PC-3 cell
migration from data shown in panel B. Two to three fields on each filter
were scored for cell migration under an inverted microscope. Data
represent percent cell migration normalized to control siRNA-trans-
fected cells treated with DMSO (mean 6 SD, n = 6; combined data from
two independent experiments each performed in triplicate). aSignifi-
cantly different (P,0.05) compared with respective DMSO-treated
controls (cells transfected with control siRNA or Notch4-targeted siRNA)
by one-way ANOVA followed by Bonferroni’s multiple comparison test.
Each experiment was performed twice.
doi:10.1371/journal.pone.0044957.g006
Sulforaphane Activates Notch
PLOS ONE | www.plosone.org 8 September 2012 | Volume 7 | Issue 9 | e44957
Methods
Ethics Statement
We used archived tissue sections from our previously published
in vivo study [8] to determine the effect of SFN administration on
expression of cleaved Notch1, cleaved Notch2, and HES-1
proteins. Use of mice and their care was approved by and in
accordance with the University of Pittsburgh Institutional Animal
Care and Use Committee guidelines.
Reagents and Cell Lines
The SFN was synthesized as described by Conaway et al. [6],
whereas its naturally-occurring analogs were purchased from LKT
Laboratories (St. Paul, MN). Stock solutions of SFN and its
analogs were prepared in DMSO, stored at 220uC, and diluted
with fresh media immediately before use. The same volume of
DMSO (final concentration ,0.1%) was added to the control
samples. Cell culture reagents such as fetal bovine serum,
antibiotics mixtures, phosphate-buffered saline (PBS), and trypsin
were purchased from Invitrogen-Life Technologies (Carlsbad,
CA). Antibodies against cleaved Notch1, and full-length Notch2
were from Cell Signaling Technology (Danvers, MA); an antibody
specific for detection of cleaved Notch2 was from EMD-Millipore
(Billerica, MA); antibodies against full-length Notch1, Notch4 (this
antibody detects both full-length and cleaved forms), and HES-1
were from Santa Cruz Biotechnology (Santa Cruz, CA); and anti-
actin antibody was from Sigma-Aldrich (St. Louis, MO). Small
interfering RNAs targeted against Notch1, Notch2, and Notch4
were purchased from Santa Cruz Biotechnology. A nonspecific
control siRNA was purchased from Qiagen (Germantown, MD).
PC-3 and LNCaP human prostate cancer cell lines were obtained
from American Type Culture Collection (Manassas, VA) and
cultured as described previously [14,24]. LNCaP-C4-2B cell line
was purchased from UroCor and maintained as suggested by the
supplier.
Immunoblotting
Whole cell lysates were prepared as described [36] and
subjected to sodium dodecyl-sulfate polyacrylamide gel electro-
phoresis [36,37]. The wet-transferred membrane was incubated
with appropriate primary and secondary antibodies and the
immunoreactive bands were detected using enhanced chemilumi-
nescence method. Multiplexing or stripping/re-probing was
performed for some proteins in some experiments.
Luciferase Reporter Assay
The transcriptional activity of Notch was determined using
a Cignal RBP-Jk luciferase reporter kit (SABiosciences-Qiagen)
following the supplier’s recommendations. For determination of
the HES-1A/B and HEY-1 luciferase activity, we used pGL2-
HES-1A/B and pGL2-HEY-1 plasmids generously given to us by
Dr. Kimberly E. Foreman (Department of Pathology, Loyola
Figure 7. Effect of D, L-sulforaphane (SFN) administration on cleaved Notch1, cleaved Notch2, and HES-1 proteins in vivo. (A)
Representative immunohistochemical images depicting expression of cleaved Notch1, cleaved Notch2, and HES-1 proteins in the prostatic
intraepithelial neoplasia (PIN), well-differentiated prostate cancer (WD), and poorly-differentiated prostate cancer (PD) in the dorsolateral prostates
from TRAMP mice of the indicated groups (6200 objective magnification). (B) Quantitation of expression (combined analysis in PIN, WD, and PD) is
shown as H-score (mean 6 SD; n = 5). Statistical significance was determined by Student’s t-test.
doi:10.1371/journal.pone.0044957.g007
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University Medical Center, Maywood, IL). The transiently co-
transfected cells with firefly luciferase plasmid and renilla luciferase
using FuGENE6 (Roche Applied Science, Indianapolis, IN) were
treated with DMSO (control) or SFN for 8 or 24 hours. Luciferase
activity was measured by Dual-Luciferase Reporter Assay System
(Promega, Madison, WI) following the manufacturer’s protocols.
Relative luciferase activity, the ratio of firefly-to-renilla luciferase
activity, was normalized against protein concentration.
Immunocytochemistry for HES-1
Cells grown on coverslips for overnight were treated with
DMSO (control) or SFN for 24 hours, fixed with 2% para-
formaldehyde for 1 hour at room temperature, and permeabilized
using 0.5% Triton X-100 for 5 minutes. Cells were then blocked
with PBS supplemented with 0.5% bovine serum albumin and
0.15% glycine for 1 hour and then incubated with anti-HES-1
antibody at 4uC for overnight. Next day, cells were treated with
2 mg/mL of Alexa Fluor-488-conjugated secondary antibody for
1 hour at room temperature. After washing with PBS cells were
treated with 50 ng/mL of 49,6-diamidino-2-phenylindole for
7 minutes at room temperature to stain nuclear DNA. Cells were
visualized under a fluorescence microscope.
RNA Interference
Cells were transfected at ,50% confluency with 200 nmol/L of
Notch1, Notch2, and Notch4-targeted siRNA or a nonspecific
control siRNA using Oligofectamine (Invitrogen-Life Technolo-
gies). Twenty-four hours after transfection, the cells were treated
with DMSO (control) or SFN for 24 hours. Subsequently, the cells
were collected and processed for western blotting as well as for
assessments of cell migration and apoptosis.
Measurement of Apoptosis and Cell Migration
Histone-associated DNA fragment release into the cytosol was
quantified using an ELISA kit (Roche Applied Science) according
to the supplier’s instructions. Transwell Boyden chambers contain-
ing 8.0 mm pore size polycarbonate filter (Corning-Life Sciences,
Lowell, MA) were used to determine cell migration. The cells
transfected with a nonspecific control siRNA or Notch1-, Notch2-,
or Notch4-targeted siRNAs were used for cell migration assay
described by us previously [30,38].
Immunohistochemistry
Tissue sections were immunostained with antibodies against
cleaved Notch1, cleaved Notch2, and HES-1 as described by us
previously for other proteins [37]. Immunohistochemical analysis
was performed using Nuclearv9.1 algorithm of Aperio Image-
Scope software (Aperio Technologies, Vista, CA). Results are
presented as H-score.
Statistical Analysis
All statistical tests were performed using GraphPad Prism v.4.03
software (GraphPad Software, La Jolla, CA).
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